Table 1.

Characteristics of 46 survivors treated for childhood MB/CNS-PNET

Gender, n (%)
Female	22 (48)
Male	24 (52)
Diagnosis, n (%)
MB	40 (87)
CNS-PNET	6 (13)
Age at treatment, mean ± SD (years)	8.5 ± 5.2 (range 0.2–19.2)
Age at study examination, mean ± SD (years)	27 ± 12.8 (range 5.5–51.9)
Time since treatment, mean ± SD (years)	18.9 ± 12 (range 3.2–40.4)
Treated with surgery, n (%)
Yes	46 (100)
Treated with chemotherapy, n (%)
Yes	38 (82.6)
Including alkylating agents	18
Including vincristine	37
No	8 (17.4)
Treated with CSI, n (%)
Yes	40 (87)
Mean dose of CSI (Gy)	31.6 (range 23.4–36)
No	6 (13)

MB medulloblastoma, CNS-PNET central nervous system supratentorial primitive neuroectodermal tumor, CSI craniospinal irradiation